Thank you, Mr. Chair.
Mr. Routledge, Mr. Tardif, thank you for being here with us.
I would just like to add that we applaud this vision wholeheartedly.
I have a few questions on guideline B‑15, which was released last month. What has been the reaction from institutions and investment funds to this guideline?